SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 89.46M
March 31, 2026 89.20M
December 31, 2025 88.47M
September 30, 2025 86.70M
June 30, 2025 86.46M
March 31, 2025 84.22M
December 31, 2024 91.32M
September 30, 2024 88.08M
June 30, 2024 82.10M
March 31, 2024 77.44M
December 31, 2023 64.51M
September 30, 2023 61.60M
June 30, 2023 58.63M
Date Value
March 31, 2023 54.66M
December 31, 2022 50.04M
September 30, 2022 45.61M
June 30, 2022 41.04M
March 31, 2022 34.18M
December 31, 2021 27.86M
September 30, 2021 21.46M
June 30, 2021 15.68M
March 31, 2021 11.88M
December 31, 2020 9.717M
September 30, 2020 6.455M
June 30, 2020 4.128M
March 31, 2020 2.294M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
NeuroPace, Inc. 66.09M
Accuray, Inc. 86.17M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 557.80M
ResMed, Inc. 1.120B